Premature Ovarian Insufficiency (POI), formerly called premature menopause, is a distinct condition with its own guidelines.

What is POI? It is the loss of ovarian function before age 40. It affects 1% of women under 40 and 0.1% under 30. Unlike natural menopause, ovarian function may be intermittent — some women resume periods and even conceive spontaneously.

Diagnosis: Two elevated FSH measurements (>25 IU/L) taken 4-6 weeks apart in a woman under 40 with oligo/amenorrhea for at least 4 months.

Treatment: NICE and ESHRE strongly recommend HRT for POI unless contraindicated — the benefits far outweigh the risks at this age. Hormone therapy should continue until the average age of natural menopause (around 51).

Fertility: Egg freezing should be discussed at diagnosis. Spontaneous pregnancy is possible but rare. Donor eggs with IVF are the most reliable fertility option.

Long-term health: Women with POI have higher risks of osteoporosis, cardiovascular disease, and cognitive decline. Regular bone density scans, cardiovascular monitoring, and lifelong HRT (until ~51) are recommended.